ICON Total Long-Term Assets 2010-2025 | ICLR
ICON total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
- ICON total long-term assets for the quarter ending March 31, 2025 were $13.307B, a 1.38% decline year-over-year.
- ICON total long-term assets for 2024 were $13.347B, a 1.7% decline from 2023.
- ICON total long-term assets for 2023 were $13.578B, a 2.71% decline from 2022.
- ICON total long-term assets for 2022 were $13.956B, a 3.39% decline from 2021.
| ICON Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $13,347 |
| 2023 | $13,578 |
| 2022 | $13,956 |
| 2021 | $14,446 |
| 2020 | $1,333 |
| 2019 | $1,283 |
| 2018 | $1,024 |
| 2017 | $1,046 |
| 2016 | $868 |
| 2015 | $854 |
| 2014 | $709 |
| 2013 | $589 |
| 2012 | $538 |
| 2011 | $475 |
| 2010 | $370 |
| 2009 | $373 |
| ICON Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $13,307 |
| 2024-12-31 | $13,347 |
| 2024-09-30 | $13,432 |
| 2024-06-30 | $13,365 |
| 2024-03-31 | $13,493 |
| 2023-12-31 | $13,578 |
| 2023-09-30 | $13,610 |
| 2023-06-30 | $13,740 |
| 2023-03-31 | $13,857 |
| 2022-12-31 | $13,956 |
| 2022-09-30 | $13,954 |
| 2022-06-30 | $14,106 |
| 2022-03-31 | $14,293 |
| 2021-12-31 | $14,446 |
| 2021-09-30 | $14,525 |
| 2021-06-30 | $1,299 |
| 2021-03-31 | $1,298 |
| 2020-12-31 | $1,333 |
| 2020-09-30 | $1,294 |
| 2020-06-30 | $1,280 |
| 2020-03-31 | $1,286 |
| 2019-12-31 | $1,283 |
| 2019-09-30 | $1,265 |
| 2019-06-30 | $1,252 |
| 2019-03-31 | $1,167 |
| 2018-12-31 | $1,024 |
| 2018-09-30 | $1,020 |
| 2018-06-30 | $1,026 |
| 2018-03-31 | $1,056 |
| 2017-12-31 | $1,046 |
| 2017-09-30 | $1,051 |
| 2017-06-30 | $879 |
| 2017-03-31 | $873 |
| 2016-12-31 | $868 |
| 2016-09-30 | $892 |
| 2016-06-30 | $841 |
| 2016-03-31 | $858 |
| 2015-12-31 | $854 |
| 2015-09-30 | $796 |
| 2015-06-30 | $657 |
| 2015-03-31 | $652 |
| 2014-12-31 | $709 |
| 2014-09-30 | $558 |
| 2014-06-30 | $567 |
| 2014-03-31 | $422 |
| 2013-12-31 | $853 |
| 2013-09-30 | $424 |
| 2013-06-30 | $421 |
| 2013-03-31 | $413 |
| 2012-12-31 | $370 |
| 2012-09-30 | $377 |
| 2012-06-30 | $374 |
| 2012-03-31 | $382 |
| 2011-12-31 | $307 |
| 2011-09-30 | $306 |
| 2011-06-30 | $243 |
| 2011-03-31 | $243 |
| 2010-12-31 | $199 |
| 2010-09-30 | $195 |
| 2010-06-30 | $191 |
| 2010-03-31 | $189 |
| 2009-12-31 | $194 |
| 2009-09-30 | $204 |
| 2009-06-30 | $200 |
| 2009-03-31 | $192 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.802B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.452B | 25.78 |
| Elevance Health (ELV) | United States | $85.620B | 11.05 |
| CVS Health (CVS) | United States | $80.443B | 10.00 |
| Cencora (COR) | United States | $56.509B | 19.66 |
| Natera (NTRA) | United States | $21.868B | 0.00 |
| DiDi Global (DIDIY) | China | $21.650B | 32.86 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $12.848B | 13.60 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.645B | 0.00 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| Revvity (RVTY) | United States | $10.730B | 18.47 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| Doximity (DOCS) | United States | $10.051B | 46.53 |
| HealthEquity (HQY) | United States | $8.975B | 39.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| Medpace Holdings (MEDP) | United States | $8.797B | 23.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.802B | 13.33 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.121B | 38.15 |
| Bausch + Lomb (BLCO) | Canada | $4.065B | 23.96 |
| Sotera Health (SHC) | United States | $3.486B | 19.81 |
| Alignment Healthcare (ALHC) | United States | $3.035B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.984B | 38.80 |
| Concentras Parent (CON) | United States | $2.776B | 16.04 |
| Organon (OGN) | United States | $2.454B | 2.61 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.078B | 80.01 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.884B | 41.47 |
| PACS (PACS) | United States | $1.554B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.407B | 28.14 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.186B | 9.02 |
| Establishment Labs Holdings (ESTA) | $1.061B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.971B | 15.16 |
| Agilon Health (AGL) | United States | $0.940B | 0.00 |
| Nutex Health (NUTX) | United States | $0.825B | 12.46 |
| AMN Healthcare Services Inc (AMN) | United States | $0.783B | 7.33 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.620B | 4.18 |
| LifeMD (LFMD) | United States | $0.575B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| SBC Medicals (SBC) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.491B | 11.07 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.254B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.151B | 24.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.094B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| ModivCare (MODV) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |